HIGHLIGHTS
- who: Tracey L. Bonfield and collaborators from the Department of Genetics and Genome Sciences, National Center Regenerative Medicine and Pediatrics, Case Western Reserve University School of Medicine, Euclid BRB, Cleveland, OH, USA have published the paper: Human Mesenchymal Stem Cell (hMSC) Donor Potency Selection for the u201cFirst in Cystic Fibrosisu201d Phase I Clinical Trial (CEASE-CF), in the Journal: Pharmaceuticals 2023, 220 of /2023/
- what: The models that were used recapitulate many of the pathophysiologic outcomes associated with CF. The hMSCs screened in this study demonstrated significant diversity in antimicrobial and anti-inflammatory function using . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.